Expanded Summary
The presentation on antimicrobial therapies provides a comprehensive overview of both
the fundamental principles and specific antibiotic classes used in clinical practice. Key
points include:
1. Principles of Antimicrobial Therapy
Goal and Selection:
Antimicrobial therapy aims to kill or inhibit pathogens without harming host cells.
Selecting the
appropriate antibiotic involves considering the suspected pathogen, its susceptibility,
the infection site, and individual patient factors (e.g., immune status, age, renal/hepatic
function). Empiric
therapy is often initiated before culture results confirm the exact organism.
Pathogen Identification & Susceptibility Testing:
Cultures remain the mainstay for identifying pathogens, but when cultures are
nonconfirmatory, modern methods like PCR and MALDI-TOF can be used. The Minimum
Inhibitory Concentration (MIC)—the lowest concentration of an antibiotic that prevents
visible growth after 24 hours—is a critical metric for assessing drug effectiveness.
Pharmacodynamics & Dosing:
Antibiotic dosing is guided by pharmacokinetic and pharmacodynamic properties. Two
important killing patterns are:
Concentration-dependent killing: Seen with agents like aminoglycosides, where
higher drug concentrations lead to more rapid bacterial death.
Time-dependent killing: Characteristic of beta-lactams and glycopeptides, where the
duration that drug levels exceed the MIC is most important. Extended or
continuous infusions can help maximize this time.
The Postantibiotic Effect (PAE) describes the sustained suppression of bacterial growth
even after drug concentrations fall below the MIC, which may allow for less frequent
dosing.
Drug Penetration and Patient Factors:
Effective therapy requires that drugs reach the infection site. Factors like lipid
solubility, molecular weight, protein binding, and susceptibility to efflux pumps
determine whether an antibiotic can
cross barriers (e.g., the blood-brain barrier). Additionally, patient-specific factors
such as age, pregnancy status, and comorbidities (renal or hepatic dysfunction)
impact drug selection and dosing.
Resistance and Spectrum of Activity:
Antibiotics are categorized by their spectrum of activity:
Narrow-spectrum agents target specific groups of bacteria.
Broad-spectrum agents cover a wide range but may disturb normal flora
and promote superinfections (e.g., Clostridium difficile colitis).
Resistance mechanisms include enzymatic inactivation (e.g., beta-lactamase
production),
, alterations in target sites, and decreased drug uptake. Such mechanisms
necessitate the use of combination therapy or beta-lactamase inhibitors in some
cases.
The presentation on antimicrobial therapies provides a comprehensive overview of both
the fundamental principles and specific antibiotic classes used in clinical practice. Key
points include:
1. Principles of Antimicrobial Therapy
Goal and Selection:
Antimicrobial therapy aims to kill or inhibit pathogens without harming host cells.
Selecting the
appropriate antibiotic involves considering the suspected pathogen, its susceptibility,
the infection site, and individual patient factors (e.g., immune status, age, renal/hepatic
function). Empiric
therapy is often initiated before culture results confirm the exact organism.
Pathogen Identification & Susceptibility Testing:
Cultures remain the mainstay for identifying pathogens, but when cultures are
nonconfirmatory, modern methods like PCR and MALDI-TOF can be used. The Minimum
Inhibitory Concentration (MIC)—the lowest concentration of an antibiotic that prevents
visible growth after 24 hours—is a critical metric for assessing drug effectiveness.
Pharmacodynamics & Dosing:
Antibiotic dosing is guided by pharmacokinetic and pharmacodynamic properties. Two
important killing patterns are:
Concentration-dependent killing: Seen with agents like aminoglycosides, where
higher drug concentrations lead to more rapid bacterial death.
Time-dependent killing: Characteristic of beta-lactams and glycopeptides, where the
duration that drug levels exceed the MIC is most important. Extended or
continuous infusions can help maximize this time.
The Postantibiotic Effect (PAE) describes the sustained suppression of bacterial growth
even after drug concentrations fall below the MIC, which may allow for less frequent
dosing.
Drug Penetration and Patient Factors:
Effective therapy requires that drugs reach the infection site. Factors like lipid
solubility, molecular weight, protein binding, and susceptibility to efflux pumps
determine whether an antibiotic can
cross barriers (e.g., the blood-brain barrier). Additionally, patient-specific factors
such as age, pregnancy status, and comorbidities (renal or hepatic dysfunction)
impact drug selection and dosing.
Resistance and Spectrum of Activity:
Antibiotics are categorized by their spectrum of activity:
Narrow-spectrum agents target specific groups of bacteria.
Broad-spectrum agents cover a wide range but may disturb normal flora
and promote superinfections (e.g., Clostridium difficile colitis).
Resistance mechanisms include enzymatic inactivation (e.g., beta-lactamase
production),
, alterations in target sites, and decreased drug uptake. Such mechanisms
necessitate the use of combination therapy or beta-lactamase inhibitors in some
cases.
